(Q41591396)

4 October 2017

1 reference

title

Implications of early inflammation and infection in cystic fibrosis: a review of new and potential interventions (English)

1 reference

4 October 2017

0 references

Weller PH

1

1 reference

4 October 2017

publication date

1 August 1997

1 reference

4 October 2017

published in

Pediatric Pulmonology

1 reference

4 October 2017

volume

24

1 reference

4 October 2017

issue

2

1 reference

4 October 2017

page(s)

143-5; discussion 159-61

1 reference

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Diagnostic delay in cystic fibrosis: lessons from newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Mechanics and energetics of breathing in newly diagnosed infants with cystic fibrosis: effect of combined bronchodilator and chest physical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

Bronchodilator responsiveness in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C143%3A%3AAID-PPUL14%3E3.0.CO%3B2-2

10.1002/(SICI)1099-0496(199708)24:2<143::AID-PPUL14>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

4 October 2017

1 reference